E. ÖZKAN Et Al. , "Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients," ANNALS OF NUCLEAR MEDICINE , vol.25, no.6, pp.425-431, 2011
ÖZKAN, E. Et Al. 2011. Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients. ANNALS OF NUCLEAR MEDICINE , vol.25, no.6 , 425-431.
ÖZKAN, E., Tokmak, E., & KÜÇÜK, N. Ö., (2011). Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients. ANNALS OF NUCLEAR MEDICINE , vol.25, no.6, 425-431.
ÖZKAN, ELGİN, Emel Tokmak, And NURİYE ÖZLEM KÜÇÜK. "Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients," ANNALS OF NUCLEAR MEDICINE , vol.25, no.6, 425-431, 2011
ÖZKAN, ELGİN Et Al. "Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients." ANNALS OF NUCLEAR MEDICINE , vol.25, no.6, pp.425-431, 2011
ÖZKAN, E. Tokmak, E. And KÜÇÜK, N. Ö. (2011) . "Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients." ANNALS OF NUCLEAR MEDICINE , vol.25, no.6, pp.425-431.
@article{article, author={ELGİN ÖZKAN Et Al. }, title={Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients}, journal={ANNALS OF NUCLEAR MEDICINE}, year=2011, pages={425-431} }